Direct healthcare costs of sedentary behaviour in the UK

J Epidemiol Community Health. 2019 Jul;73(7):625-629. doi: 10.1136/jech-2018-211758. Epub 2019 Mar 25.

Abstract

Background: Growing evidence indicates that prolonged sedentary behaviour increases the risk of several chronic health conditions and all-cause mortality. Sedentary behaviour is prevalent among adults in the UK. Quantifying the costs associated with sedentary behaviour is an important step in the development of public health policy.

Methods: National Health Service (NHS) costs associated with prolonged sedentary behaviour (≥6 hours/day) were estimated over a 1-year period in 2016-2017 costs. We calculated a population attributable fraction (PAF) for five health outcomes (type 2 diabetes, cardiovascular disease [CVD], colon cancer, endometrial cancer and lung cancer). Adjustments were made for potential double-counting due to comorbidities. We also calculated the avoidable deaths due to prolonged sedentary behaviour using the PAF for all-cause mortality.

Results: The total NHS costs attributable to prolonged sedentary behaviour in the UK in 2016-2017 were £0.8 billion, which included expenditure on CVD (£424 million), type 2 diabetes (£281 million), colon cancer (£30 million), lung cancer (£19 million) and endometrial cancer (£7 million). After adjustment for potential double-counting, the estimated total was £0.7 billion. If prolonged sedentary behaviour was eliminated, 69 276 UK deaths might have been avoided in 2016.

Conclusions: In this conservative estimate of direct healthcare costs, prolonged sedentary behaviour causes a considerable burden to the NHS in the UK. This estimate may be used by decision makers when prioritising healthcare resources and investing in preventative public health programmes.

Keywords: cost analysis; health expenditure; healthcare cost; physical activity; public health; sedentary behaviour; sitting time.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiovascular Diseases / economics*
  • Cardiovascular Diseases / epidemiology
  • Chronic Disease
  • Colonic Neoplasms / economics*
  • Colonic Neoplasms / epidemiology
  • Comorbidity
  • Cost of Illness
  • Cost-Benefit Analysis / statistics & numerical data
  • Diabetes Mellitus, Type 2 / economics*
  • Diabetes Mellitus, Type 2 / epidemiology
  • Endometrial Neoplasms / economics*
  • Endometrial Neoplasms / epidemiology
  • Female
  • Health Care Costs / statistics & numerical data*
  • Humans
  • Lung Neoplasms / economics*
  • Lung Neoplasms / epidemiology
  • Male
  • Sedentary Behavior*
  • State Medicine / economics
  • United Kingdom / epidemiology